Ubelacker R - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.

Reiser M, Schnell R, Straub G, Borchmann P, Wilhelm M, Ubelacker R, Wörmann B, Münch R, Diehl V, Engert A. Reiser M, et al. Among authors: ubelacker r. Leuk Lymphoma. 1998 Oct;31(3-4):359-66. doi: 10.3109/10428199809059229. Leuk Lymphoma. 1998. PMID: 9869200 Clinical Trial.

Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma.

Glasmacher A, Haferlach T, Gorschlüter M, Mezger J, Maintz C, Clemens MR, Ko Y, Hahn C, Ubelacker R, Kleinschmidt R, Gieseler F. Glasmacher A, et al. Among authors: ubelacker r. Leukemia. 1997 Dec;11 Suppl 5:S22-6. Leukemia. 1997. PMID: 9436934 Clinical Trial.

IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.

Hentrich M, Fehnle K, Ostermann H, Kienast J, Cornely O, Salat C, Ubelacker R, Buchheidt D, Behre G, Hiddemann W, Schiel X. Hentrich M, et al. Among authors: ubelacker r. Crit Care Med. 2006 May;34(5):1319-25. doi: 10.1097/01.CCM.0000215452.84291.C6. Crit Care Med. 2006. PMID: 16540956 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters